Pictor Diagnostics India Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.78 Cr
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 35.36%
- Profit Growth 106.85%
- Ebitda 128.64%
- Net Worth 9.29%
- Total Assets 18.66%
About Pictor Diagnostics India
Pictor Diagnostics India Private Limited (PDIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 03 August 2016 (Eight years and six months 21 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Chakraborty and Paul Kinnon serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33127MH2016FTC284421
- Company No.
284421
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
03 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Pictor Diagnostics India Private Limited offer?
Pictor Diagnostics India Private Limited offers a wide range of products and services, including Rapid Test Kit, Dengue Test Kit, HIV Test Kit, IVDs & Analyzers, Cardiac Marker Analyzer, Diagnostic Test Kit, HCV Test Kit.
Who are the key members and board of directors at Pictor Diagnostics India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Chakraborty | Whole-Time Director | 19-Apr-2023 | Current |
| Paul Kinnon | Director | 26-Jul-2024 | Current |
Financial Performance of Pictor Diagnostics India.
Pictor Diagnostics India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.36% increase. The company also saw a substantial improvement in profitability, with a 106.85% increase in profit. The company's net worth moved up by a moderate rise of 9.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pictor Diagnostics India?
In 2021, Pictor Diagnostics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pictor Diagnostics India?
Unlock and access historical data on people associated with Pictor Diagnostics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pictor Diagnostics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pictor Diagnostics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
